Please use this identifier to cite or link to this item:
Title: Pharmaceutical development of a parenteral lypophilized dosage form
Researcher: Sreedhar B
Guide(s): Seshasai Marella
Keywords: Clinical Pre Clinical and Health,Pharmacology and Toxicology,Pharmacology and Pharmacy
University: Jawaharlal Nehru Technological University, Hyderabad
Completed Date: 2014
Abstract: The Main objective of the present work was to design, formulate and optimize the lyophilisation process for Palonosetron Hydrochloride, Azacitidine and Gemcitabine Hydrochloride molecules intended to develop as a parenteral lyophilised dosage forms. Palonosetron Hydrochloride is a 5-HT3 antagonist used to prevention of chemotherapy induced nausea and vomiting. Azacitidine is an anticancer drug used in the treatment of myelodysplastic syndrome. newlineGemcitabine hydrochloride is an anticancer drug used in various carcinomas including non-small cell lung cancer. newline
Appears in Departments:Faculty of Pharmaceutical Sciences

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File17.76 kBAdobe PDFView/Open
02_declaration.pdf287.69 kBAdobe PDFView/Open
03_certificate.pdf655.59 kBAdobe PDFView/Open
04_acknowledgement.pdf159.29 kBAdobe PDFView/Open
05_abstract.pdf143.08 kBAdobe PDFView/Open
06_contents & list of figures.pdf379.73 kBAdobe PDFView/Open
07_list of tables & abbreviations.pdf198.08 kBAdobe PDFView/Open
08_chapter 1.pdf809.79 kBAdobe PDFView/Open
09_chapter 2.pdf168.54 kBAdobe PDFView/Open
10_chapter 3.pdf233.22 kBAdobe PDFView/Open
11_chapter 4.pdf822.25 kBAdobe PDFView/Open
12_chapter 5.pdf230.12 kBAdobe PDFView/Open
13_chapter 6.pdf926.46 kBAdobe PDFView/Open
14_chapter 7.pdf172.43 kBAdobe PDFView/Open
15_references.pdf179.55 kBAdobe PDFView/Open

Items in Shodhganga are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: